This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rabbaa, L. Articles by Farinotti, R. Search for Related Content PubMed PubMed Citation Articles by Rabbaa, L. Articles by Farinotti, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Sep 1996, 2126-2130, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process

L Rabbaa, S Dautrey, N Colas-Linhart, C Carbon and R Farinotti
Service de Pharmacie Clinique, Centre Hospitalier Universitaire Bicha- Claude Bernard, Paris, France.

The aim of this work was to examine the mechanism involved in intestinal elimination of the two optical isomers of ofloxacin in the rat. An intestinal segment was isolated in situ and perfused with saline, while drug solution was administered via the carotid artery. Blood samples and intestinal effluents were collected and analyzed by a high-performance liquid chromatography method. We observed saturable and stereoselective intestinal elimination of the ofloxacin enantiomers. The elimination process favored the R-(+) form of the molecule. After a parenteral dose of 20 mg of racemic ofloxacin per kg of body weight, intestinal clearances were 0.23 +/- 0.03 versus 0.30 +/- 0.03 ml/min for S-(-)- and R-(+)-ofloxacin, respectively. Ciprofloxacin and pefloxacin interfered with ofloxacin elimination and significantly reduced the intestinal clearance of S-(-)- and R-(+)-ofloxacin. With concomitant ciprofloxacin, intestinal clearances became 0.13 +/- 0.02 versus 0.17 +/- 0.03 ml/min and 0.14 +/- 0.01 versus 0.19 +/- 0.05 ml/min with pefloxacin for S-(-)- and R-(+)-ofloxacin, respectively. Those findings argue for the presence of a common transport system in the rat intestine with variable affinities for fluoroquinolones. In addition, verapamil and quinidine, two P-glycoprotein blockers, significantly reduced the intestinal elimination of both ofloxacin isomers (with concomitant verapamil, intestinal clearances were 0.12 +/- 0.02 versus 0.18 +/- 0.03 ml/min for S-(-)- and R-(+)-ofloxacin, respectively, while with concomitant quinidine, values were 0.18 +/- 0.01 versus 0.23 +/- 0.01 ml/min without modifying their areas under the concentration-time curve in serum. Similar results were found with another fluoroquinolone, ciprofloxacin, in previous work. P- glycoprotein appears to be involved in the intestinal elimination of fluoroquinolones in rats. The characterization of fluoroquinolone intestinal elimination has significant clinical relevance for the better evaluation of the influence of this secretory pathway on antibiotic efficacy and selection of resistant bacteria within the intestinal flora.

This article has been cited by other articles:

• Zhang, D., He, K., Raghavan, N., Wang, L., Mitroka, J., Maxwell, B. D., Knabb, R. M., Frost, C., Schuster, A., Hao, F., Gu, Z., Humphreys, W. G., Grossman, S. J. (2009). Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans. Drug Metab. Dispos. 37: 1738-1748 [Abstract] [Full Text]  
• Garner, C. E., Solon, E., Lai, C.-M., Lin, J., Luo, G., Jones, K., Duan, J., Decicco, C. P., Maduskuie, T., Mercer, S. E., Gan, L.-S., Qian, M., Prakash, S., Shen, H.-S., Lee, F. W. (2008). Role of P-Glycoprotein and the Intestine in the Excretion of DPC 333 [(2R)-2-{(3R)-3-Amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in Rodents. Drug Metab. Dispos. 36: 1102-1110 [Abstract] [Full Text]  
• Vazifeh, D., Bryskier, A., Labro, M.-T. (1999). Mechanism Underlying Levofloxacin Uptake by Human Polymorphonuclear Neutrophils. Antimicrob. Agents Chemother. 43: 246-252 [Abstract] [Full Text]  
• Cormet-Boyaka, E., Huneau, J.-F., Mordrelle, A., Boyaka, P. N., Carbon, C., Rubinstein, E., Tomé, D. (1998). Secretion of Sparfloxacin from the Human Intestinal Caco-2 Cell Line Is Altered by P-Glycoprotein Inhibitors. Antimicrob. Agents Chemother. 42: 2607-2611 [Abstract] [Full Text]